Burning Rock Biotech Ltd. (BNR)
9.80
-0.52
(-5.04%)
USD |
NASDAQ |
Aug 25, 16:00
Burning Rock Biotech Enterprise Value : 28.51M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 28.51M |
| August 24, 2026 | 33.08M |
| August 21, 2026 | 28.33M |
| August 20, 2026 | 23.68M |
| August 19, 2026 | 28.42M |
| August 18, 2026 | 24.20M |
| August 17, 2026 | 22.36M |
| August 14, 2026 | 19.99M |
| August 13, 2026 | 24.03M |
| August 12, 2026 | 29.65M |
| August 11, 2026 | 33.97M |
| August 10, 2026 | 37.79M |
| August 07, 2026 | 19.81M |
| August 06, 2026 | 20.42M |
| August 05, 2026 | 20.42M |
| August 04, 2026 | 21.22M |
| August 03, 2026 | 20.07M |
| July 31, 2026 | 20.60M |
| July 30, 2026 | 20.16M |
| July 29, 2026 | 19.90M |
| July 28, 2026 | 23.15M |
| July 27, 2026 | 24.99M |
| July 24, 2026 | 21.04M |
| July 23, 2026 | 21.04M |
| July 22, 2026 | 22.71M |
| Date | Value |
|---|---|
| July 21, 2026 | 25.43M |
| July 20, 2026 | 30.88M |
| July 17, 2026 | 30.00M |
| July 16, 2026 | 26.79M |
| July 15, 2026 | 24.11M |
| July 14, 2026 | 29.74M |
| July 13, 2026 | 36.06M |
| July 10, 2026 | 41.69M |
| July 09, 2026 | 45.20M |
| July 08, 2026 | 45.64M |
| July 07, 2026 | 36.81M |
| July 06, 2026 | 33.16M |
| July 02, 2026 | 28.68M |
| July 01, 2026 | 21.13M |
| June 30, 2026 | 15.94M |
| June 29, 2026 | 13.40M |
| June 26, 2026 | 15.07M |
| June 25, 2026 | 12.25M |
| June 24, 2026 | 17.26M |
| June 23, 2026 | 8.827M |
| June 22, 2026 | 10.32M |
| June 18, 2026 | 6.104M |
| June 17, 2026 | 4.259M |
| June 16, 2026 | 13.84M |
| June 15, 2026 | 19.37M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 400.26M |
| BioRestorative Therapies, Inc. | 2.111M |
| CareDx, Inc. | 2.261B |
| Natera, Inc. | 47.50B |
| Exagen, Inc. | 186.94M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.523M |
| Revenue (Quarterly) | 15.59M |
| Total Expenses (Quarterly) | 18.11M |
| EPS Diluted (Quarterly) | -0.2399 |
| Gross Profit Margin (Quarterly) | 72.27% |
| Profit Margin (Quarterly) | -16.19% |
| Earnings Yield | -8.04% |
| Normalized Earnings Yield | -8.041 |